Flagship health tech event ‘Re-defining the Healthcare Landscape – The Digital Shift,’ held in Bengaluru
AstraZeneca and NASSCOM – CoE IOT have strengthened their collaboration to foster digital solutions for addressing Non-Communicable Diseases (NCDs) in India. Recently NASSCOM LHIF (Lifesciences & Healthcare Innovation Forum) organised a day-long flagship health tech event ‘Re-defining the Healthcare Landscape – The Digital Shift,’ in Bengaluru. Around 300+ participants from across the life sciences and healthcare supply chain attended from all over India.
LHIF is a platform created by NASSCOM to drive digital transformation in the lifesciences and healthcare industry. The forum is one of the largest neutral eco-systems comprising stakeholders from pharma industry, medtech companies, health insurance organisations, hospitals, radiology and imaging companies, technology companies, industry associations, startups, academia and government bodies.
Keynotes were given by Pankaj Kumar Pandey, Commissioner, Commissionerate – Health, Family Welfare and AYUSH Services, Govt of Karnataka, Dr Devi Shetty, Chairman and Executive Director, Narayana Health, Nalinikanth Gollagunta, MD, Wipro GE Healthcare, Niclas Jacobson, Deputy Director, Ministry of Health and Social Affairs, Government of Sweden and Gagan Singh, MD, AstraZeneca Pharma India.
The event discussed a wide range of topics in healthcare such as MedTech innovation in healthcare, the digital doctor of the future, societal impact through health tech, cloud computing in healthcare & lifesciences, building a unified digital health platform and current trends in healthcare today. Sankara Nethralaya Medical Research Foundation presented a collection of industry success stories in digital adoption.
In addition, the #LHIF Startup Awards were presented to SIX high-impact and tech-driven healthcare startups breaking new ground in innovation and healthcare.
Speaking on the occasion, Debjani Ghosh, President, NASSCOM states, “Advanced technology adoption in Indian healthcare sector is poised for substantial growth as it continues to emerge as a game-changer in the delivery of quality healthcare services. Technological innovations and interventions are crucial to convert today’s expensive medical discoveries into affordable solutions. The NASSCOM LHIF is an important step in developing a closer partnership between health-tech companies, global healthcare organisations, academia and the government to work collaboratively in deploying proven innovation to solve critical healthcare challenges present today and at pace to enable the local population to get the best and most efficient healthcare services possible. NASSCOM’s collaboration with AstraZeneca is one such effort in this area to further promote digitally-enabled technologies, across regions, so that evidence can be generated, and tech adoption is scaled at speed, both domestically and internationally.”
Delivering the opening keynote address at the forum, Singh from AstraZeneca Pharma India shared that both NASSCOM and AstraZeneca are committed to strengthening their collaboration towards driving the digital healthcare agenda. Singh said, “This partnership will focus on healthcare delivery interventions via digital technologies and collaboration towards healthcare innovation centres showcasing the impact of such solutions across the patient journey, from early diagnosis, to treatment and wellness. NASSCOM and AstraZeneca’s have an existing partnership under the iDREAM programme – a health tech start-up accelerator programme and incubation centre in Bengaluru that supports start-ups in bringing innovative and frugal solutions that can help in the management of NCDs in India and beyond.”
NASSCOM also collaborated with China痴 IｷCampus to accelerate healthcare innovation and cooperation in life sciences and healthcare sector. The (I·Campus) is an innovation incubation platform offering services in R&D, commercialisation and professional services in the life sciences industry, co-built by the Wuxi Municipal Government, the Wuxi National High-tech District and AstraZeneca. The collaboration will support healthcare tech start-ups accelerate healthcare innovation and promote international cooperation and development of the lifesciences and healthcare industry across the borders.